V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004932 | 300003383 | 1.77 | 76 | Adjuvant (A) | 2017-04-17 | 2017-04-23 | Carboplatin + Etoposide iv&po | 01 | N | 300026240 | GEMCARBO |
| 300004933 | 300003384 | 1.8 | 82 | Adjuvant (A) | 2017-03-07 | 2017-03-28 | GemCarbo Days 1+8 | 02 | N | 300026242 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004934 | 300003384 | 1.83 | 76.8 | Palliative (P) | 2014-01-22 | 2014-01-30 | GEMCARBO | 02 | N | 300026242 | CAPECITABINE + CISPLATIN |
| 300004935 | 300003384 | null | 80.2 | Neo-adjuvant (N) | 2016-07-31 | 2016-08-01 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 300026242 | CARBO + FLUOROURACIL |
| 300004936 | 300003385 | 1.78 | null | Palliative (P) | 2016-08-04 | 2016-08-04 | GemCarbo Days 1+8 | 01 | N | 300026264 | OXALIPLATIN + MDG |
| 300004937 | 300003386 | 1.61 | null | Curative (C) | 2013-07-15 | 2013-07-15 | Carboplatin + Etoposide iv&po | N | Y | 300026279 | FLUOROURACIL + MITOMYCIN |
| 300004938 | 300003387 | 1.6 | 17.7 | null | 2016-11-11 | 2016-11-17 | Carboplatin + Etoposide iv&po | 02 | N | 300026280 | CARBOPLATIN |
| 300004939 | 300003387 | 1.51 | 70 | Adjuvant (A) | 2014-06-24 | 2014-06-24 | CARBOPLATIN + FLUOROURACIL | 02 | N | 300026280 | TRASTUZUMAB |
| 300004940 | 300003388 | null | 72.9 | Disease modification (D) | 2013-07-20 | 2013-08-12 | Carboplatin+Fluorouracil 4 or 5 day | Y | N | 300026294 | CAPECITABINE + OXALIPLATIN |
| 300004941 | 300003389 | 1.55 | null | Palliative (P) | 2014-11-14 | 2014-12-05 | PEMBROLIZUMAB | null | N | 300026300 | PACLITAXEL |
| 300004942 | 300003390 | 1.63 | 60.1 | Adjuvant (A) | 2014-12-25 | 2015-01-04 | Capecitabine + Cisplatin | N | N | 300026302 | PEMBROLIZUMAB |
| 300004943 | 300003390 | 1.58 | 86 | Palliative (P) | 2015-07-22 | 2015-07-28 | Oxaliplatin + Modified de Gramont | N | N | 300026302 | CISPLATIN + FLUOROURACIL + RT |
| 300004944 | 300007520 | 1.47 | 69 | Palliative (P) | 2016-01-05 | 2016-01-25 | FLUOROURACIL + MITOMYCIN | N | N | 300026304 | FEC |
| 300004945 | 300007520 | 1.48 | null | Adjuvant (A) | 2013-06-01 | 2013-06-27 | Carboplatin + Etoposide iv&po | N | Y | 300026304 | CAPECITABINE + OXALIPLATIN |
| 300004946 | 300003391 | null | 76 | Curative (C) | 2016-08-17 | 2016-09-28 | CARBOPLATIN + FLUOROURACIL | 2 | N | 300026310 | OXALIPLATIN + MDG |
| 300004947 | 300003392 | null | -1 | Palliative (P) | null | 2016-02-08 | MAESTRO TRIAL | N | N | 300026317 | DACARBAZINE |
| 300004948 | 300006252 | 1.7 | 72 | Palliative (P) | 2014-03-04 | 2014-03-20 | Carboplatin + Etoposide iv&po | 02 | N | 300026318 | CARBOPLATIN + RT |
| 300004949 | 300006252 | 1.62 | 61 | Palliative (P) | 2013-05-14 | 2013-05-14 | FLUOROURACIL + MITOMYCIN | 2 | N | 300026318 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004950 | 300006252 | 1.5 | 54.8 | Adjuvant (A) | 2013-11-17 | 2013-11-20 | Paclitaxel 7 day | 1 | N | 300026318 | IPILIMUMAB + NIVOLUMAB |
| 300004951 | 300006252 | 1.8 | 87 | Palliative (P) | 2015-03-30 | 2015-04-07 | ESPAC-4 TRIAL | N | N | 300026318 | CAPECITABINE + RT |
| 300004953 | 300003394 | null | 90.4 | Palliative (P) | 2018-05-22 | 2018-05-22 | Hydroxycarbamide | 02 | null | 300026335 | ESPAC TRIAL |
| 300004954 | 300003395 | null | null | Palliative (P) | 2013-11-18 | 2013-11-25 | DABRAFENIB | 02 | N | 300026338 | FLUOROURACIL + MITOMYCIN |
| 300004955 | 300003396 | 1.59 | 80.9 | Palliative (P) | 2017-07-22 | 2017-07-23 | PEMBROLIZUMAB | 01 | N | 300000030 | CARBOPLATIN + ETOPOSIDE |
| 300004956 | 300003396 | 1.77 | 65.6 | Disease modification (D) | 2015-07-22 | 2015-07-22 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 300000030 | CAPECITABINE + GEMCITABINE |
| 300004957 | 300003397 | 1.7 | 96 | null | 2014-04-19 | 2014-04-26 | ECX | 1 | N | 300000076 | ECARBOX |
| 300004958 | 300003397 | 1.8 | 125.7 | Curative (C) | 2016-10-08 | 2016-11-11 | Gemcitabine + Capecitabine | N | N | 300000076 | DE-ESCALATE TRIAL |
| 300004959 | 300003398 | 1.89 | 74.1 | Palliative (P) | 2015-05-19 | 2015-05-23 | GemCarbo Days 1+8 | N | N | 300000260 | GEMCARBO |
| 300004960 | 300003399 | 1.58 | null | Neo-adjuvant (N) | 2016-09-08 | 2016-10-15 | Temozolomide + RT | N | N | 300000384 | CAPECITABINE + GEMCITABINE |
| 300004961 | 300003400 | 1.59 | 57.4 | Curative (C) | 2015-12-07 | 2015-12-16 | Folfirinox | N | N | 300000468 | GEMCARBO |
| 300004962 | 300003401 | 1.7 | 80 | Palliative (P) | 2015-08-25 | 2015-08-28 | Capecitabine + Oxaliplatin 21day | 02 | null | 300000482 | CARBO + FLUOROURACIL |
| 300004963 | 300003402 | null | 59.3 | Palliative (P) | 2015-10-29 | 2015-11-19 | CARBOPLATIN | 02 | N | 300000597 | GEMCARBO |
| 300004964 | 300003402 | 1.63 | 73.8 | Palliative (P) | 2019-04-20 | 2019-04-21 | IPILIMUMAB + NIVOLUMAB | 2 | N | 300000597 | CARBOPLATIN + ETOPOSIDE |
| 300004965 | 300003402 | 1.76 | 82.4 | Palliative (P) | 2016-08-22 | 2016-08-22 | CARBOPLATIN | 2 | N | 300000597 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004966 | 300003403 | 1.7 | 59 | Palliative (P) | 2015-03-10 | 2015-04-09 | Gemcitabine + Capecitabine | N | N | 300000665 | CARBOPLATIN + ETOPOSIDE |
| 300004967 | 300003403 | null | 59.4 | Curative (C) | 2014-07-30 | 2014-08-07 | CARBOPLATIN + RT | 2 | Y | 300000665 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004968 | 300003404 | null | null | Palliative (P) | 2018-01-03 | 2018-01-17 | Oxaliplatin + Raltitrexed | 02 | N | 300000725 | BCG |
| 300004969 | 300003405 | 1.8 | null | null | 2015-11-26 | 2015-12-03 | Capecitabine 35days + RT | N | null | 300000934 | CARBO + FLUOROURACIL |
| 300004970 | 300003406 | 1.73 | 94 | Palliative (P) | 2014-09-04 | 2014-09-23 | CARBOPLATIN + RT | Y | N | 300000991 | CARBO + FLUOROURACIL |
| 300004971 | 300003407 | 1.78 | 88.9 | Palliative (P) | 2017-08-13 | 2017-08-15 | Dacarbazine | 02 | N | 300001072 | CAPECITABINE + GEMCITABINE |
| 300004972 | 300003408 | null | 74.3 | Palliative (P) | 2018-02-21 | 2018-02-27 | ESPAC-4 TRIAL | 02 | N | 300001117 | DE-ESCALATE TRIAL |
| 300004973 | 300006257 | 1.55 | 77.9 | Adjuvant (A) | 2018-01-26 | 2018-02-09 | CARBOPLATIN | N | N | 300001159 | FLUOROURACIL + MITOMYCIN |
| 300004974 | 300003409 | 1.47 | 58.5 | Palliative (P) | 2015-04-11 | 2015-04-24 | Folfirinox | 02 | N | 300001222 | NOT MATCHED |
| 300004975 | 300003409 | 1.64 | 55.3 | Palliative (P) | 2016-11-15 | 2016-11-15 | Oxaliplatin + Modified de Gramont | N | N | 300001222 | DABRAFENIB + TRAMETINIB |
| 300004976 | 300003410 | 1.68 | 46 | Curative (C) | 2018-06-24 | 2018-07-27 | PEMBROLIZUMAB | null | Y | 300001258 | GEMCITABINE + OXALIPLATIN |
| 300004977 | 300003410 | 1.56 | 76.1 | Palliative (P) | 2016-12-03 | 2016-12-17 | Vemurafenib | N | N | 300001258 | CAPECITABINE + CISPLATIN |
| 300004978 | 300003411 | 1.48 | 57.8 | Adjuvant (A) | 2017-10-17 | 2017-10-29 | Cisplatin + Vinorelbine (IV) | 02 | N | 300001299 | TRASTUZUMAB |
| 300004979 | 300003411 | 1.69 | 80 | Adjuvant (A) | 2016-10-26 | 2016-10-26 | PEMBROLIZUMAB | N | null | 300001299 | CARBOPLATIN + ETOPOSIDE |
| 300004980 | 300007523 | 1.76 | null | Palliative (P) | 2016-05-14 | 2016-05-27 | Carboplatin + Etoposide iv&po | N | N | 300001458 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004981 | 300007523 | 1.78 | null | null | 2017-02-13 | 2017-02-13 | Carboplatin+Fluorouracil 4 or 5 day | null | null | 300001458 | OXALIPLATIN + RALTITREXED |
| 300004982 | 300003412 | 1.57 | 75.5 | Curative (C) | null | 2017-01-09 | ESPAC-4 TRIAL | N | N | 300001503 | FEC + DOCETAXEL |